Matches in Nanopublications for { ?s ?p "DDI between Ziprasidone and Flecainide - Additive QTc-prolonging effects may increase the risk of severe arrhythmias. Concomitant therapy is contraindicated. [drugbank_resource:DB00246_DB01195]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.